Bayer's Betaseron found efficacious in multiple sclerosis patients

Multiple Sclerosis :: Bayer's Betaseron found efficacious in multiple sclerosis patients

Bayer HealthCare Pharmaceuticals announced the results of three clinical studies with Betaseron? (interferon beta-1b), presented this week at the American Academy of Neurology's (AAN) 59th Annual Meeting, demonstrating early efficacy, long-term tolerability, and high patient satisfaction with treatment in patients with relapsing forms of multiple sclerosis (MS).

"Collectively, these studies highlight the important clinical benefits and long-term safety and tolerability of Betaseron treatment," said Ludger Heeck, Ph.D., Vice President and General Manager, Specialized Therapeutics, Bayer HealthCare Pharmaceuticals. "Betaseron is the first immunomodulatory MS treatment shown to significantly delay disability and disease progression in patients with the first event suggestive of MS. In addition, key attributes, such as a high level of patient satisfaction and tolerability of the medication, may help improve a person's adherence to treatment and consequently, the effectiveness of the treatment."

In the first study, known as BENEFIT[1] (BEtaseron in Newly Emerging multiple sclerosis For Initial Treatment), immediate initiation of Betaseron?treatment in patients after a first event suggestive of MS significantly reduced the risk of disability as measured by the Expanded Disability Status Scale (EDSS) by 40 percent[2]. The results of the prospectively designed and blinded study were measured over three years and compared early treatment to delayed treatment, defined as receiving treatment after the second clinical event or after two years.

About Betaseron

Betaseron (Interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.




(Multiple Sclerosis :: Bayer's Betaseron found efficacious in multiple sclerosis patients published at SpiritIndia on Tuesday, May 8, 2007)

Multiple Sclerosis

Search more information on Multiple Sclerosis, Multiple Sclerosis books

Recently posted related articles on Multiple Sclerosis :

1. Multiple Sclerosis :: Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease
2. Multiple Sclerosis :: MS that runs in families appears more severe than non-familial MS
3. Multiple Sclerosis :: Accentia announces investigational new drug application for Revimmune for refractory MS
4. Multiple Sclerosis :: Antibody leads to repair of myelin sheath in lab study of multiple sclerosis and related disorders
5. Smoking :: Smoking has no effect on progression of multiple sclerosis
6. Multiple Sclerosis :: Patients own stem cells injected to treat multiple sclerosis
7. Multiple Sclerosis :: Cell-surface sugar defects may trigger nerve damage in multiple sclerosis patients
8. Multiple Sclerosis :: Waddell Center Experts Conduct Multiple Sclerosis Symposium
9. MRI :: New MRI finding sheds light on multiple sclerosis disease progression
10. Multiple Sclerosis :: Fish oil might help multiple sclerosis patients

Most related articles:

- Multiple Sclerosis :: Bayer's Betaseron found efficacious in multiple sclerosis patients
- Multiple Sclerosis :: Ultra-high-field MRI allows for earlier diagnosis of multiple sclerosis - 17.8
- Multiple Sclerosis :: Be aware of diverse symptoms of multiple sclerosis - 17.5
- Multiple Sclerosis :: Multiple sclerosis more in women than men - 17.2
- Multiple Sclerosis :: Multiple Sclerosis is not a terminal disease - 17
- Multiple Sclerosis :: Ultra-high-field MRI allows for earlier diagnosis of multiple sclerosis - 16.9
- Multiple Sclerosis :: Alarming trend shows women face higher risk for MS - 16.2
- Multiple Sclerosis :: Teva & Active Biotech to initiate trial of oral laquinimod for relapsing multiple sclerosis - 15.2
- Multiple Sclerosis :: Yoga n fatigue relief in multiple sclerosis - 15.1
- Multiple Sclerosis :: Interferon beta-1b for patients with multiple sclerosis - 14.5

Multiple Sclerosis - recent related articles/news stories:

- Smoking increases brain lesions and brain shrinkage in MS
- Smoking leads to rapid progression of multiple sclerosis
- 2 new locations of genes causing multiple sclerosis
- UK's MS Society supports Carers Week
- Breastfeeding reduces multiple sclerosis relapse in women

»»   Acne :: Bayer & Intendis to co-promote YAZ for acne treatment
««   Diet :: Research team sheds light on diet of early human ancestors

Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT | Glossary | List

AYUSH = Ayurveda - Yoga - Unani - Siddha - Homeopathy -- Health articles

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Spirit India comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com